Antimicrobial "Bug Spray" Found In Human Lung Cells

June 18, 1997

Hopkins scientists studying lung damage from cystic fibrosis (CF) have found a natural "bug spray" that lung cells "squirt" on attacking bacteria.

The "spray", an antimicrobial compound researchers call hTAP(human tracheal antimicrobial peptide), appears to be disabled in CF patients, increasing their vulnerability to lung infections. If researchers can mass-produce hTAP or similar compounds, they may help fight lung infections in both CF patients and in the general population, where infectious lung diseases like tuberculosis kill more than 7 million people every year.

"People have always thought that the lungs only attacked infections via the classical immune system--B cells, T cells and other immune cells," says Pete Pedersen, Ph.D., Hopkins professor of biological chemistry. "But lung cells apparently have their own first-line defense mechanism--they shoot out one or more peptides that kill bacteria."

After the first such compounds were identified in cells from frog skin and cow throats by researchers at other institutions Young Hee Ko, a research associate in Pedersen's lab, suspected that CF jammed the "nozzle" on a similar bug spray.

"That nozzle is a channel on the surface of lung cells called CFTR, and we already knew that CF disrupts it," says Ko.

In a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Cystic Fibrosis Foundation, Ko exposed two batches of lung cells, one from a normal patient and one from a CF patient, to Pseudomonas aeruginosa, a bacterium that causes repeated lung infections in CF patients.

The bacteria infected many CF cells while making little progress in the normal cells. Ko then searched for an antimicrobial compound similar to the one found in cow throats, and found hTAP.

Pedersen speculates that cells in other areas at high risk for infection, such as the eyes, the gut or the mouth, may secrete similar germ-fighting compounds.

Their results were published recently in the journal FEBS (Federation of European Biochemical Societies) Letters. The other study author was Michael Delannoy, an electron microscopist.


Johns Hopkins Medicine

Related Cystic Fibrosis Articles from Brightsurf:

Treating cystic fibrosis with mRNA therapy or CRISPR
The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation.

Cystic fibrosis: why so many respiratory complications?
Cystic fibrosis, one of the most common genetic diseases in Switzerland, causes severe respiratory and digestive disorders.

A newly discovered disease may lead to better treatment of cystic fibrosis
Cystic fibrosis is the most frequent severe inherited disorder worldwide.

New treatment kills off infection that can be deadly to cystic fibrosis patients
The findings, which are published in the journal Scientific Reports, show that scientists from Aston University, Mycobacterial Research Group, combined doses of three antibiotics -- amoxicillin and imipenem-relebactam and found it was 100% effective in killing off the infection which is usually extremely difficult to treat in patients with cystic fibrosis.

Cystic fibrosis carriers are at increased risk for cystic fibrosis-related conditions
A University of Iowa study challenges the conventional wisdom that having just one mutated copy of the cystic fibrosis (CF) gene has no effects on a person's health.

Rare mutations drive cystic fibrosis in Caribbean
Cystic Fibrosis (CF) in the Caribbean is dominated by unusual gene mutations not often observed in previously studied CF populations, according to comprehensive genome sequencing led by physician-scientists at UC San Francisco and Centro de Neumología Pediátrica in San Juan.

Cystic fibrosis carriers at increased risk of digestive symptoms
Researchers have found that carriers of the most common genetic variant that causes cystic fibrosis experience some symptoms similar to those of people with cystic fibrosis.

In cystic fibrosis, lungs feed deadly bacteria
A steady supply of its favorite food helps a deadly bacterium thrive in the lungs of people with cystic fibrosis, according to a new study by Columbia researchers.

Cibio knocks out cystic fibrosis
The fight against cystic fibrosis continues, targeting in particular some of the mutations that cause it.

Hypertonic saline may help babies with cystic fibrosis breathe better
Babies with cystic fibrosis may breathe better by inhaling hypertonic saline, according to a randomized controlled trial conducted in Germany and published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Read More: Cystic Fibrosis News and Cystic Fibrosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to